Astellas Press Release: Chertsey, England
Astellas today announces its flagship programme, Action on Fistula, has given 2,164 Kenyan women with obstetric fistula life changing reconstructive surgery, including one woman who had waited 51 years for treatment.
Action on Fistula, a ground-breaking partnership between Fistula Foundation and Astellas Pharma EMEA, was set up to transform the lives of more than 1,200 women in Kenya living with Fistula: a condition caused by prolonged obstructed labour, leading to faecal or urinary incontinence or both. It most commonly occurs among women who live in rural communities in low-resource countries, who are not aware that help is available or are unable to reach a hospital.
The programme, launched three years ago, aims to increase access to and awareness of treatment while simultaneously building capacity in the country to deliver on‐going surgeries. Since launch, the programme has significantly increased surgical capacity in Kenya to treat the condition, by training six fistula surgeons to global competency standards set forth by the International Federation of Gynecology and Obstetrics. It has also set up a Fistula Treatment Network to extend access to services, with six treatment centres enrolled and providing fistula surgeries on a routine basis. This has enabled Action on Fistula to exceed its treatment target by an impressive 80%.
- Ground-breaking campaign ends one woman’s 51 year wait for surgical treatment
- Programme has significantly increased surgical capacity in Kenya to treat fistula
- Women from 43 of Kenya’s 47 counties have received life-changing care
Kate Grant, CEO, Fistula Foundation, comments, “Astellas’ investment in Fistula Foundation has done something truly transformational, not just for Kenya but for the field of fistula treatment. More facilities in Kenya now provide routine fistula treatment, more surgeons are delivering this care, and more communities know that this devastating injury exists, and that it can be treated for free.
“The impact of Action on Fistula has stretched far beyond help to individual women. Couples, families and entire communities have benefited from both the surgeries that helped restore a woman’s place as a contributing member of her society, and from sensitisation initiatives that destigmatise this injury and empower other women to step forward for treatment.”
To ensure women living with fistula in rural communities can be identified and helped, Action on Fistula is also running a major outreach programme, and training community workers to identify and encourage patients to access treatment. Through the programme, five local organisations have trained 222 community health workers, conducted 6,545 outreach activities and reached 412,000 community members in 43 of Kenya’s 47 counties.
Yukio Matsui, President of Astellas Pharma EMEA, said, “Fistula is a condition that devastates the lives of women and their families. In addition to the physical impact of incontinence, it leaves many women ostracised from their loved ones and communities. Action on Fistula was created to reach and treat women suffering the consequences of this.
“We are delighted that Action on Fistula has transformed the lives of over 2,000 women so far through access to treatment. We look forward to continuing our relationship with the Fistula Foundation so that many more women can receive this life changing treatment they so desperately need.”
Whilst virtually eradicated in developed countries, the United Nations Population Fund (UNFPA) estimates 3,000 new cases of obstetric fistula occur annually in Kenya, with approximately one to two fistulas for every 1,000 deliveries.
Women with fistula are often subject to severe social stigma due to odour, which is constant and humiliating, and in many cases drives the patients’ family, friends and neighbours away. Stigmatised, these women are also often denied access to education and employment and left to live lives of isolation and poverty.
Alongside funding Action on Fistula, Astellas is actively encouraging and enabling employees to fundraise to support fistula treatment.
For more information about the programme ,visit www.astellas.eu/action‐on‐fistula
 United Nations Population Fund, Direct Relief and Fistula Foundation Global Treatment Map at http://www.globalfistulamap.org/
Published on: Jan 26, 2017